Fcer1g Knockout cell line(RAW 264.7)
Catalog Number: KO01224
Price: Online Inquiry
Catalog Number: KO01224
Price: Online Inquiry
Product Information | |
---|---|
Product Name | Fcer1g Knockout cell line(RAW 264.7) |
specification | 1*10^6 |
Storage and transportation | Dry ice preservation/T25 live cell transportation. |
Cell morphology | monocyte-like, Adherent cells |
Passage ratio | 1:2-1:3 |
species | Mouse |
Gene | Fcer1g |
Gene ID | 14127 |
Build method | Electric rotation method / virus method |
Mycoplasma testing | Negative |
Cultivation system | 90%DMEM+10%FBS |
Parental Cell Line | RAW 264.7 |
Quality Control | Genotype: Fcer1g Knockout cell line(RAW 264.7) >95% viability before freezing. All cells were tested and found to be free of bacterial, viruses,mycoplasma and other toxins. |
Gene Information | |
---|---|
Gene Official Full Name | Fc receptor, IgE, high affinity I, gamma polypeptideprovided by MGI |
Also known as | CD23; Fce1g; Ly-50; FcR[g]; FcRgamma; FcR-gamma; FcepsilonRI |
Gene Description | Enables IgE receptor activity; identical protein binding activity; and immunoglobulin binding activity. Involved in several processes, including cell surface receptor signaling pathway; positive regulation of interleukin-4 production; and serotonin secretion by platelet. Acts upstream of or within several processes, including immune response-regulating cell surface receptor signaling pathway; positive regulation of cytokine production; and positive regulation of immune effector process. Located in external side of plasma membrane. Part of Fc-epsilon receptor I complex. Is expressed in central nervous system; gut; male reproductive gland or organ; and retina. Orthologous to human FCER1G (Fc epsilon receptor Ig). [provided by Alliance of Genome Resources, Apr 2025] |
Expression | Broad expression in spleen adult (RPKM 104.3), mammary gland adult (RPKM 62.3) and 23 other tissues See more |
We develop gene knockout solutions tailored to customer requirements and the condition of the target gene.
Cas9 Protein
Cas9 mRNA sgRNA
Cas9 Plasmid
Cas9 Virus
A – Exon KO
gRNAs are designed in the introns flanking the exon, targeting non-multiple-of-3 base deletions in the exon, resulting in frameshift mutations.
B - Frameshift KO
gRNAs are designed within the exon, creating non-multiple-of-3 base deletions to induce frameshift mutations.
C - Complete KO
The entire gene coding sequence is deleted, achieving large-scale knockout effects.
KO Strategy Design
CRISPR Plasmid/Lentiviral Vector Construction
Lentiviral Packaging
Cell Transfection/Lentiviral Infection
Drug Selection
Cell Cryopreservation
Quality Control
Sequencing Validation
Monoclonal Cell Line Generation
Pool Efficiency Validation
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.